Hirokazu Makishima

1.0k total citations
48 papers, 617 citations indexed

About

Hirokazu Makishima is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Surgery. According to data from OpenAlex, Hirokazu Makishima has authored 48 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 15 papers in Hepatology and 10 papers in Surgery. Recurrent topics in Hirokazu Makishima's work include Radiation Therapy and Dosimetry (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers) and Advanced Radiotherapy Techniques (8 papers). Hirokazu Makishima is often cited by papers focused on Radiation Therapy and Dosimetry (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers) and Advanced Radiotherapy Techniques (8 papers). Hirokazu Makishima collaborates with scholars based in Japan, United States and Taiwan. Hirokazu Makishima's co-authors include Tadashi Kamada, Osama Mohamad, Hiroshi Tsuji, Goro Kasuya, Shigeo Yasuda, Masashi Mizumoto, Shigeru Yamada, Daniel K. Ebner, Hitoshi Ishikawa and Hirohiko Tsujii and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Hirokazu Makishima

43 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirokazu Makishima Japan 14 384 193 138 114 106 48 617
Takuma Nomiya Japan 16 461 1.2× 213 1.1× 161 1.2× 166 1.5× 103 1.0× 47 736
Shuichi Kanamori Japan 15 322 0.8× 173 0.9× 212 1.5× 184 1.6× 38 0.4× 27 663
H. Ortíz Puerto Rico 7 238 0.6× 107 0.6× 127 0.9× 99 0.9× 33 0.3× 14 609
Alessia Surgo Italy 15 446 1.2× 203 1.1× 147 1.1× 287 2.5× 72 0.7× 38 792
Ah Ram Chang South Korea 12 166 0.4× 147 0.8× 145 1.1× 112 1.0× 119 1.1× 44 510
J Anderson Australia 9 216 0.6× 100 0.5× 173 1.3× 181 1.6× 429 4.0× 19 681
Naomi Jiang United States 7 219 0.6× 217 1.1× 68 0.5× 193 1.7× 33 0.3× 11 560
K. Nakajima Japan 10 248 0.6× 90 0.5× 44 0.3× 49 0.4× 52 0.5× 46 387
Yoshiki Kubota Japan 14 322 0.8× 300 1.6× 53 0.4× 177 1.6× 46 0.4× 62 587
Jinbo Yue China 15 307 0.8× 80 0.4× 102 0.7× 293 2.6× 44 0.4× 54 688

Countries citing papers authored by Hirokazu Makishima

Since Specialization
Citations

This map shows the geographic impact of Hirokazu Makishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Makishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Makishima more than expected).

Fields of papers citing papers by Hirokazu Makishima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokazu Makishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Makishima. The network helps show where Hirokazu Makishima may publish in the future.

Co-authorship network of co-authors of Hirokazu Makishima

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Makishima. A scholar is included among the top collaborators of Hirokazu Makishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Makishima. Hirokazu Makishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makishima, Hirokazu, Naoyuki Hasegawa, Takafumi Ikeda, et al.. (2025). Proton Beam Therapy for Untreated Hepatocellular Carcinoma Unsuitable for Transcatheter Arterial Chemoembolization. Liver Cancer. 1–10.
2.
Mizumoto, Masashi, Yinuo Li, Masatoshi Nakamura, et al.. (2024). Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma. Cancers. 16(2). 357–357. 4 indexed citations
3.
Ogasawara, Sadahisa, Keisuke Koroki, Hirokazu Makishima, et al.. (2024). Phase Ib trial of durvalumab plus tremelimumab in combination with particle therapy in advanced hepatocellular carcinoma patients with macrovascular invasion: DEPARTURE trial.. Journal of Clinical Oncology. 42(3_suppl). 480–480.
4.
Mizumoto, Masashi, Toshiyuki Okumura, Hirokazu Makishima, et al.. (2024). Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study. Cancers. 16(11). 2050–2050. 5 indexed citations
6.
Kaneko, Takashi, Hirokazu Makishima, Masaru Wakatsuki, et al.. (2024). Carbon-ion radiotherapy for hepatocellular carcinoma with major vascular invasion: a retrospective cohort study. BMC Cancer. 24(1). 383–383. 4 indexed citations
7.
Wakatsuki, Masaru, Takashi Kaneko, Hirokazu Makishima, et al.. (2023). Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis. Cancer Medicine. 12(13). 14004–14014. 8 indexed citations
8.
Mizumoto, Masashi, Hiroko Fukushima, Toshio Miyamoto, et al.. (2023). Analysis of person-hours required for proton beam therapy for pediatric tumors. Journal of Radiation Research. 64(3). 599–601. 1 indexed citations
9.
Mizumoto, Masashi, Kazuki Terashima, Hirokazu Makishima, et al.. (2023). Proton Beam Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study in Japan. Liver Cancer. 13(2). 161–168. 2 indexed citations
11.
Saito, Takashi, Masashi Mizumoto, Kei Nakai, et al.. (2022). Factors Involved in Preoperative Edema in High-Grade Gliomas. Cureus. 14(11). e31379–e31379. 2 indexed citations
12.
Mizumoto, Masashi, Yoshiko Oshiro, Toshio Miyamoto, et al.. (2022). Abnormal sensation during total body irradiation: a prospective observational study. Journal of Radiation Research. 63(5). 792–795. 2 indexed citations
13.
Iizumi, Takashi, Toshiyuki Okumura, Kazushi Maruo, et al.. (2021). 943P Long-term outcome of the oldest-old patients (85 years or older) underwent proton beam therapy for hepatocellular carcinoma. Annals of Oncology. 32. S824–S824.
14.
Yamada, Shigeru, Hirotoshi Takiyama, Yuka Isozaki, et al.. (2021). Carbon-ion Radiotherapy for Colorectal Cancer. SHILAP Revista de lepidopterología. 5(2). 113–120. 9 indexed citations
15.
Bhattacharyya, Tapesh, Masashi Koto, Hiroaki Ikawa, et al.. (2019). First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry. British Journal of Radiology. 92(1103). 20190370–20190370. 11 indexed citations
16.
Mohamad, Osama, Takahiro Tabuchi, Akihiro Nomoto, et al.. (2019). Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study. The Lancet Oncology. 20(5). 674–685. 63 indexed citations
17.
Yamada, Shigeru, Tadashi Kamada, Daniel K. Ebner, et al.. (2016). Carbon-Ion Radiation Therapy for Pelvic Recurrence of Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(1). 93–101. 58 indexed citations
18.
Hashimoto, Takayuki, Hiroichi Ishikawa, Toshiyuki Okumura, et al.. (2012). Concurrent Chemo-Proton Therapy Using 5-fluorouracil and Cisplatin for Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 84(3). S311–S312. 2 indexed citations
19.
Kar, Sarah Abu, Ania Jankowska, Hirokazu Makishima, et al.. (2012). Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia. Haematologica. 98(1). 107–113. 61 indexed citations
20.
Fukuda, Takeshi, Hirokazu Makishima, Ashok Mulchandani, et al.. (2010). Organophosphorus compound detection on a cell chip with yeast coexpressing hydrolase and eGFP. Biotechnology Journal. 5(5). 515–519. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026